RAP 0.00% 20.5¢ raptor resources limited

Conference Call Summary, page-322

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 27,755 Posts.
    lightbulb Created with Sketch. 1791
    This is from their last adult clinical/trial study, clearly RAP uses trial and study interchangeably. You still need to cough and get confirm whether the diagnosis are correct or not......so I don't think you are correct there. They are way pass gathering data and training the algorithm.

    "Correctly detected lower respiratory tract disease in 84% of adult patients initially diagnosed as clear by experienced clinicians using stethoscopes"

    "ResApp’s US paediatric clinical study is also progressing well. SMARTCOUGH-C is a prospective, multi-site, double-blind study that will evaluate the efficacy of the ResAppDx software application in the diagnosis of childhood pneumonia and other respiratory conditions from cough sounds."
    Last edited by AlCp: 11/08/17
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.